Glaxosmithkline Capital Inc: 25-NSE filed Sep 15, 2022

Form type

25-NSE

Filing date

Sep 15, 2022

Accession number

0000876661-22-000756

Filer

Glaxosmithkline Capital Inc (CIK 1224462)